Class II · Moderate risk
Xtandi 40 mg capsule NDC 00469-0125-99 30 days supply
Lack of Processing Controls.
FDA Drug Recalls
1,590 recalls, newest first
Class II · Moderate risk
Pomalyst 3 mg capsule NDC 59572-0503-21 28 days supply
Lack of Processing Controls.
Class II · Moderate risk
Tecfidera 240 mg capsule NDC 64406-0006-02 30 days supply
Lack of Processing Controls.
Class II · Moderate risk
Copaxone 20 mg Injection PFS
Lack of Processing Controls.
Class II · Moderate risk
Copaxone 40 mg Injection
Lack of Processing Controls.
Class II · Moderate risk
Praluent 75 mg Pen
Lack of Processing Controls.
Class II · Moderate risk
Cimzia 200 mg/mL PFS Kit #2 NDC 50474-0710-79 28 days supply.
Lack of Processing Controls.
Class II · Moderate risk
Stelara 90 mg/MI PFS NDC 57894-0061-03 84 days supply
Lack of Processing Controls.
Class II · Moderate risk
Boost VHC Oral Liquid VAN #27 NDC 43900-0182-15 27 days supply
Lack of Processing Controls.
Class II · Moderate risk
Dupixent 300 mg/2 mL PFS #2 w/ NS NDC 00024-5914-01 28 days supply
Lack of Processing Controls.
Class II · Moderate risk
Vosevi 400/100/100 mg Tablets #28 NDC 61958-2401-01 28 days supply.
Lack of Processing Controls.
Class II · Moderate risk
Xolair 150 mg SDV NDC 50242-0040-62 28 days
Lack of Processing Controls.
Class II · Moderate risk
Sodium Chloride 3% Inh. 4 mL NEP #30 NDC 00487-9003-60 30 days supply.
Lack of Processing Controls.
Class II · Moderate risk
MVW Complete Softgels NDC 58204-0004-00 30 days supply
Lack of Processing Controls.
Class II · Moderate risk
Creon DR 24
Lack of Processing Controls.
Class II · Moderate risk
Azithromycin 250 mg tablet #18 TEV NDC 50111-0787-66 28 days supply
Lack of Processing Controls.
Class II · Moderate risk
Pulmozyme 1 mg/mL Inh. Soln. #30 NDC 50242-0100-40 30 days supply.
Lack of Processing Controls.
Class II · Moderate risk
Bethkis 300 mg/4 mL Ampule #56 NDC 10122-0820-56 56 days supply
Lack of Processing Controls.
Class II · Moderate risk
Orkambi 100 mg/125 mg Tablets #112 NDC 51167-0700-02 28 days supply.
Lack of Processing Controls.
Class II · Moderate risk
Orkambi 200 mg/125 mg Tablets #112 NDC 51167-0809-01 28 days supply.
Lack of Processing Controls.
Class II · Moderate risk
Kitabis Pak 300 mg/5 mL Soln PARI #56 NDC 24492-0850-56 56 days supply
Lack of Processing Controls.
Class II · Moderate risk
Prolia 60 mg/1 mL PF syringe NDC 55513-0710-01 180 days supply.
Lack of Processing Controls.
Class II · Moderate risk
Botox 100 Units Vial NDC 00023-1145-01 90 days supply.
Lack of Processing Controls.
Class II · Moderate risk
Enbrel PFS 50 mg/mL Inj #4 NDC 58406-0435-04 28 days supply
Lack of Processing Controls.
Class II · Moderate risk
Repatha 140 mg/mL Sureclick AI 2-pk NDC 55513-0760-02 28 days supply
Lack of Processing Controls.